Kevin Krenitsky - Net Worth and Insider Trading
Kevin Krenitsky Net Worth
The estimated net worth of Kevin Krenitsky is at least $7,063 dollars as of 2024-04-25. Kevin Krenitsky is the President, Enzo Clinical Labs of Enzo Biochem Inc and owns about 6,600 shares of Enzo Biochem Inc (ENZ) stock worth over $7,062. Kevin Krenitsky is also the President of OpGen Inc and owns about 1 shares of OpGen Inc (OPGN) stock worth over $1. Details can be seen in Kevin Krenitsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin Krenitsky has not made any transactions after 2015-05-08 and currently still holds the listed stock(s).
Transaction Summary of Kevin Krenitsky
Kevin Krenitsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Krenitsky owns 3 companies in total, including OpGen Inc (OPGN) , Foundation Medicine Inc (FMI) , and Enzo Biochem Inc (ENZ) .
Click here to see the complete history of Kevin Krenitsky’s form 4 insider trades.
Insider Ownership Summary of Kevin Krenitsky
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OPGN | OpGen Inc | 2015-05-08 | President |
| FMI | Foundation Medicine Inc | 2014-10-01 | Chief Commercial Officer & SVP |
| ENZ | Enzo Biochem Inc | 2009-10-15 | President & Enzo Clinical Labs |
Kevin Krenitsky Latest Holdings Summary
Kevin Krenitsky currently owns a total of 2 stocks. Among these stocks, Kevin Krenitsky owns 6,600 shares of Enzo Biochem Inc (ENZ) as of October 15, 2009, with a value of $7,062 and a weighting of 99.99%. Kevin Krenitsky also owns 1 shares of OpGen Inc (OPGN) as of May 8, 2015, with a value of $1 and a weighting of 0.01%.
Latest Holdings of Kevin Krenitsky
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENZ | Enzo Biochem Inc | 2009-10-15 | 6,600 | 1.07 | 7,062 |
| OPGN | OpGen Inc | 2015-05-08 | 1 | 0.53 | 1 |
Holding Weightings of Kevin Krenitsky
Kevin Krenitsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Krenitsky has made a total of 0 transactions in Enzo Biochem Inc (ENZ) over the past 5 years. The most-recent trade in Enzo Biochem Inc is the acquisition of 6,600 shares on October 15, 2009, which cost Kevin Krenitsky around $50,820.
According to the SEC Form 4 filings, Kevin Krenitsky has made a total of 0 transactions in OpGen Inc (OPGN) over the past 5 years. The most-recent trade in OpGen Inc is the acquisition of 1 shares on May 8, 2015, which cost Kevin Krenitsky around $50,004.
Insider Trading History of Kevin Krenitsky
- 1
Kevin Krenitsky Trading Performance
GuruFocus tracks the stock performance after each of Kevin Krenitsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Krenitsky is -24.83%. GuruFocus also compares Kevin Krenitsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Krenitsky within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Krenitsky's insider trading performs compared to the benchmark.
Performance of Kevin Krenitsky
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.6 | -24.83 | -35.37 | -57.72 | -47 | -54.73 |
| Relative Return to S&P 500(%) | -8.59 | -25.72 | -40.22 | -59.95 | -53.08 | -63.52 |
Kevin Krenitsky Ownership Network
Ownership Network List of Kevin Krenitsky
Ownership Network Relation of Kevin Krenitsky
Kevin Krenitsky Owned Company Details
What does OpGen Inc do?
Who are the key executives at OpGen Inc?
Kevin Krenitsky is the President of OpGen Inc. Other key executives at OpGen Inc include Chief Operating Officer Johannes Bacher , Chief Finanical Officer Albert Weber , and director & Chief Executive Officer Oliver Schacht .
OpGen Inc (OPGN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of OpGen Inc (OPGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OpGen Inc (OPGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
OpGen Inc (OPGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
OpGen Inc Insider Transactions
Kevin Krenitsky Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Krenitsky. You might contact Kevin Krenitsky via mailing address: C/o Opgen, Inc., 708 Quince Orchard Road, Suite 205, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
